The Traderszone Network

Published in TZ Latest News 2 September, 2014 by The TZ Newswire Staff

Biotechnology ETFs Show Robust Health In August

Sell in May and go away? Not with this summer’s hot action. In August, investors dumped ETFs that short the stock market — and picked up a healthy shot of gains from biotechnology funds. First Trust NYSE Arca Biotech (FBT) popped 14% to an all-time high last month, outperforming all nonleveraged ETFs. It has rocketed 57% from a 52-week low of 59.09 amid a brightening sector outlook.

read more